Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00432939 · ClinicalTrials.gov registry record

Primary Hyperparathyroidism: Non-classical Manifestations

A clinical trial, sponsored by Columbia University.

Completed
Registry status
58
Enrollment target

NCT00432939 is a clinical trial that has completed, run by Columbia University. The registered enrollment target is 58 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00432939 has completed, sponsored by Columbia University.

COMPLETED
Registry status
58 participants
Enrollment target

Study Summary

This is a research study to investigate cardiovascular health in people with mild hyperparathyroidism. Previous research has suggested that severe hyperparathyroidism may be associated with abnormalities in the heart and blood vessels. It is unclear whether mild hyperparathyroidism affects cardiovascular health. This study involves the investigation of the heart and blood vessels of people with mild hyperparathyroidism. Various non-invasive laboratory and radiological test to assess cardiovascular and bone health will be done at set intervals over the course of 2 years. It is our hypothesis that patients with primary hyperparathyroidism will have subtle abnormalities in their cardiovascular system. Using state-of-the art techniques that are sufficiently sensitive to detect these subtle abnormalities, we will define cardiovascular features of this disease that have, up to now, eluded clear definition. We expect taht the extent of these findings will be related to the severity of the underlying primary hyperparathyroidism. We further hypothesize that cardiovascular manifestations may regress with successful cure of the hyperparathyroid state.

Trial Details

FieldValue
Enrollment Target 58 participants
Start Date 2005-10
Est. Completion 2012-12

Sponsor

Columbia University

958 total trials

What the Registry Record Tells You About NCT00432939

The ClinicalTrials.gov registry entry for NCT00432939 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 58 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Columbia University, which has 958 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 0 interventions.

NCT00432939 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT00432939 about?

NCT00432939 is a clinical study titled "Primary Hyperparathyroidism: Non-classical Manifestations". This is a research study to investigate cardiovascular health in people with mild hyperparathyroidism. Previous research has suggested that severe hyperparathyroidism may be associated with abnormalities in the heart and blood vessels. It is unclear whether mild hyperparathyroidism affects cardiovas...

What is the current status of trial NCT00432939?

This trial is currently completed. The enrollment target is 58 participants. The study started on 2005-10. Estimated completion is 2012-12.

Who is sponsoring clinical trial NCT00432939?

This trial is sponsored by Columbia University, which has 958 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.